35
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Senescent cells evade immune clearance via HLA-E-mediated NK and CD8 + T cell inhibition

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Senescent cells accumulate in human tissues during ageing and contribute to age-related pathologies. The mechanisms responsible for their accumulation are unclear. Here we show that senescent dermal fibroblasts express the non-classical MHC molecule HLA-E, which interacts with the inhibitory receptor NKG2A expressed by NK and highly differentiated CD8 + T cells to inhibit immune responses against senescent cells. HLA-E expression is induced by senescence-associated secretary phenotype-related pro-inflammatory cytokines, and is regulated by p38 MAP kinase signalling in vitro. Consistently, HLA-E expression is increased on senescent cells in human skin sections from old individuals, when compared with those from young, and in human melanocytic nevi relative to normal skin. Lastly, blocking the interaction between HLA-E and NKG2A boosts immune responses against senescent cells in vitro. We thus propose that increased HLA-E expression contributes to persistence of senescent cells in tissues, thereby suggesting a new strategy for eliminating senescent cells during ageing.

          Abstract

          Senescent cells increase with ageing and may cause inflammatory conditions, but how this accumulation is mediated is still unclear. Here the authors show that senescent cells express HLA-E to suppress NKG2A-mediated natural killer and CD8 T cell activation to avoid targeted elimination, while blocking NKG2A helps promote immunity against senescent cells.

          Related collections

          Most cited references58

          • Record: found
          • Abstract: found
          • Article: not found

          The senescence-associated secretory phenotype: the dark side of tumor suppression.

          Cellular senescence is a tumor-suppressive mechanism that permanently arrests cells at risk for malignant transformation. However, accumulating evidence shows that senescent cells can have deleterious effects on the tissue microenvironment. The most significant of these effects is the acquisition of a senescence-associated secretory phenotype (SASP) that turns senescent fibroblasts into proinflammatory cells that have the ability to promote tumor progression.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Aging, Cellular Senescence, and Cancer

            For most species, aging promotes a host of degenerative pathologies that are characterized by debilitating losses of tissue or cellular function. However, especially among vertebrates, aging also promotes hyperplastic pathologies, the most deadly of which is cancer. In contrast to the loss of function that characterizes degenerating cells and tissues, malignant (cancerous) cells must acquire new (albeit aberrant) functions that allow them to develop into a lethal tumor. This review discusses the idea that, despite seemingly opposite characteristics, the degenerative and hyperplastic pathologies of aging are at least partly linked by a common biological phenomenon: a cellular stress response known as cellular senescence. The senescence response is widely recognized as a potent tumor suppressive mechanism. However, recent evidence strengthens the idea that it also drives both degenerative and hyperplastic pathologies, most likely by promoting chronic inflammation. Thus, the senescence response may be the result of antagonistically pleiotropic gene action.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

              Human aging is characterized by a chronic, low-grade inflammation, and this phenomenon has been termed as "inflammaging." Inflammaging is a highly significant risk factor for both morbidity and mortality in the elderly people, as most if not all age-related diseases share an inflammatory pathogenesis. Nevertheless, the precise etiology of inflammaging and its potential causal role in contributing to adverse health outcomes remain largely unknown. The identification of pathways that control age-related inflammation across multiple systems is therefore important in order to understand whether treatments that modulate inflammaging may be beneficial in old people. The session on inflammation of the Advances in Gerosciences meeting held at the National Institutes of Health/National Institute on Aging in Bethesda on October 30 and 31, 2013 was aimed at defining these important unanswered questions about inflammaging. This article reports the main outcomes of this session. © The Author 2014. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
                Bookmark

                Author and article information

                Contributors
                a.akbar@ucl.ac.uk
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                3 June 2019
                3 June 2019
                2019
                : 10
                : 2387
                Affiliations
                [1 ]ISNI 0000000121901201, GRID grid.83440.3b, Division of Infection and Immunity, , University College London, ; London, WC1E 6JF UK
                [2 ]ISNI 0000000121901201, GRID grid.83440.3b, Institute of Histopathology, , Great Ormond Street Hospital for Children, University College London, ; London, WC1N 3JH UK
                [3 ]ISNI 0000000121901201, GRID grid.83440.3b, Paediatric Dermatology Department, , Great Ormond Street Hospital for Children, University College London, ; London, WC1N 3JH UK
                [4 ]ISNI 0000 0000 8687 5377, GRID grid.272799.0, Buck Institute for Research on Aging, ; 8001 Redwood Blvd, Novato, CA 94945 USA
                [5 ]ISNI 0000 0001 0462 7212, GRID grid.1006.7, Institute for Cell and Molecular Biosciences & Newcastle University Institute for Ageing, ; Newcastle upon Tyne, NE1 7RU UK
                [6 ]ISNI 0000 0004 0459 167X, GRID grid.66875.3a, Department of Physiology and Biomedical Engineering, , Mayo Clinic, ; Rochester, 55905 MN USA
                [7 ]ISNI 0000000121965555, GRID grid.42629.3b, Department of Applied Sciences, , Faculty of Health and Life Sciences, Northumbria University, ; Newcastle Upon Tyne, NE1 8ST UK
                [8 ]ISNI 0000 0001 2231 4551, GRID grid.184769.5, Lawrence Berkeley National Laboratory, ; 1 Cyclotron Rd, Berkeley, CA 94720 USA
                Author information
                http://orcid.org/0000-0003-0990-8835
                http://orcid.org/0000-0003-1861-9357
                Article
                10335
                10.1038/s41467-019-10335-5
                6547655
                31160572
                398b020c-8842-4847-9bfc-75408d6f8c66
                © The Author(s) 2019

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 1 May 2018
                : 2 May 2019
                Funding
                Funded by: .B.I.P. was supported by the Portuguese Foundation for Science and Technology and Gulbenkian Institute for Science sponsoring the Advanced Medical Program for Physicians (PFMA)
                Funded by: O.D. was supported by an MB PhD funding award from the National Institute for Health Research University College London Hospitals Biomedical Research Centre
                Funded by: FundRef https://doi.org/10.13039/100000009, Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.);
                Award ID: AG052744
                Award ID: AG051729
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100000265, RCUK | Medical Research Council (MRC);
                Award ID: MR/P00184X/1
                Award ID: MR/M003833/1
                Award Recipient :
                Funded by: Dermatrust
                Categories
                Article
                Custom metadata
                © The Author(s) 2019

                Uncategorized
                senescence,nk cells,cd8-positive t cells,ageing
                Uncategorized
                senescence, nk cells, cd8-positive t cells, ageing

                Comments

                Comment on this article